prevention of ovarian hyperstimulation syndrome in patients with polycystic ovarian syndrome by using midfollicular fsh/lh ratio and counting number(s) of ovarian follicles
نویسندگان
چکیده
the objective of this study was to examine the correlation between both midfollicular fsh/lh ratio and number(s) of follicles with ovarian hyperstimulation syndrome (ohss) in patients with polycystic ovarian syndrome (pcos). this was carried out in ivf unit at mirza kouchak khan hospital. to induce ovulation, pcos patients were stimulated with gonadotropines. fifty four pcos patients with normal basal level of fsh, lh were studied prospectively. 22 patients did not receive hcg and stimulation cycle was canceled due to ohss. 32 patients received hcg and stimulation cycle was completed. in all patients mid-follicular (day 8 of stimulation protocol) serum fsh/lh ratio was measured. on the same day number of ovarian follicles were also counted using vaginal sonography. in canceled cycles, lh on day 8 was shown to be low along with increased number of follicles. the risk of cycle cancelation raised twice with one increment of fsh/lh ratio. also, with increase of one follicle the risk of cycle cancellation increased 1.3 times. to induce ovulation by gonadotropine stimulation in pcos patients, the dose should be carefully monitored. measuring fsh/lh ratio and number of follicles on day 8 of stimulation protocol are reliable guides in order to predict those patients prone to develop ohss.
منابع مشابه
Prevention of Ovarian Hyperstimulation Syndrome
Ovarian hyperstimulation syndrome (OHSS) is rare but most serious complication of ovarian stimulation. Symptoms are mainly related to increased capillary permeability leading to extravasation of fluid into extravascular compartment. Disease pathophysiology is linked to hCG (human chorionic gonadotropin) which acts through angiogenic molecule vascular endothelial growth factor (VEGF). There is r...
متن کاملRole of serum miRNAs in the prediction of ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients.
BACKGROUND Polycystic ovarian syndrome (PCOS) causes a significantly increased risk of ovarian hyperstimulation syndrome (OHSS). Here, we focused on the altered expression of serum miRNAs and their predictive value for OHSS in PCOS patients. METHODS We used the TaqMan low density array followed by individual quantitative reverse transcription-polymerase chain reaction to identify and validate...
متن کاملP-207: Pharmacogenetic Study of CYP19A1 (Aromatase) in Ovarian Induction in Iranian Polycystic Ovarian Syndrome Patients
Background: Hyper-androgenemia is one of the main clinical features of polycystic ovarian syndrome (PCOS). Letrozol is an aromatase inhibitor drug, which is co-administered with gonadotropins in most cases of PCOS, to improve ovulation. Aromatase has a critical role in catalyzing the conversion of androgens to estrogens and is responsible for keeping the homeostatic balance between them. Hence ...
متن کاملPrevention and treatment of ovarian hyperstimulation syndrome.
The ovarian hyperstimulation syndrome (OHSS) is a potentially fatal condition with a pathophysiology that is not clearly understood. A shift in fluid from the extravascular space occurs, thought to be induced by cytokines and/or vascular endothelial growth factor. Human chorionic gonadotrophin (hCG), exogenous or endogenous, seems to be the triggering mechanism, resulting in early and late deve...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
مجله دانشکده پزشکی دانشگاه علوم پزشکی تهرانجلد ۵۹، شماره ۱، صفحات ۵۹-۶۳
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023